无线电技术
医学
前列腺癌
多参数磁共振成像
回顾性队列研究
观察研究
放射科
磁共振成像
前瞻性队列研究
肿瘤科
梅德林
临床试验
前列腺
内科学
基准标记
癌症
试验预测值
作者
Mengxuan Yuan,Di Chang,Wanjun Lu,Kaiyang Ma,Yue Gu,Tianyi Xia,Jian Peng,Yang Zhang,Lei Fu,Ben Zhao
标识
DOI:10.1186/s12967-026-07848-1
摘要
BACKGROUND: Current preoperative assessment faces limitations, including PI-RADS scoring subjectivity and diagnostic uncertainty in distinguishing high-risk prostate cancer from benign and low-risk lesions. To develop an interpretable ensemble learning framework integrating habitat-based radiomics and peritumoral analysis from multiparametric MRI for preoperative high-risk prostate cancer prediction. METHODS: This retrospective, multi-institutional study included 896 patients with suspected prostate lesions and histopathologically confirmed diagnoses across three centers (January 2018-December 2024). Intratumoral habitat analysis used K-means clustering; peritumoral analysis evaluated 1 mm, 3 mm, and 5 mm expansion rings. Feature selection used minimum Redundancy Maximum Relevance (mRMR) and LASSO regression. Models were validated externally with SHAP analysis for interpretability. RESULTS: The cohort comprised 398 training, 171 internal validation, and 327 external validation patients. The habitat signature achieved superior performance with AUCs of 0.827 (95% CI: 0.768-0.886) and 0.855 (95% CI: 0.795-0.915) in external validation cohorts, significantly outperforming intratumoral signatures (AUCs: 0.774 and 0.629, p < 0.001) and clinical signatures (AUCs: 0.791 and 0.712, p < 0.001). The 3 mm peritumoral signature performed best (AUC: 0.782-0.793). The combined model achieved the highest performance (AUC: 0.860-0.876). SHAP analysis showed ADC-derived features dominated importance, with habitat region H3 contributing > 70% of selected features. CONCLUSION: Integrated habitat and peritumoral radiomics provide robust preoperative risk stratification for prostate cancer, with superior performance from ADC-derived habitat features. TRIAL REGISTRATION: Not applicable. This was a retrospective observational study without prospective trial registration.
科研通智能强力驱动
Strongly Powered by AbleSci AI